Humacyte Statistics Share Statistics Humacyte has 155.12M
shares outstanding. The number of shares has increased by 29.78%
in one year.
Shares Outstanding 155.12M Shares Change (YoY) 29.78% Shares Change (QoQ) 0.94% Owned by Institutions (%) 46.26% Shares Floating 125.44M Failed to Deliver (FTD) Shares 37,658 FTD / Avg. Volume 0.84%
Short Selling Information The latest short interest is 32.72M, so 21.09% of the outstanding
shares have been sold short.
Short Interest 32.72M Short % of Shares Out 21.09% Short % of Float 24.29% Short Ratio (days to cover) 7.67
Valuation Ratios The PE ratio is -4.02 and the forward
PE ratio is -9.94.
Humacyte's PEG ratio is
-0.23.
PE Ratio -4.02 Forward PE -9.94 PS Ratio 0 Forward PS 3.4 PB Ratio -11.36 P/FCF Ratio -6 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Humacyte.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.4,
with a Debt / Equity ratio of -0.31.
Current Ratio 2.4 Quick Ratio 2.4 Debt / Equity -0.31 Debt / EBITDA -0.13 Debt / FCF -0.17 Interest Coverage -12.33
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-682.11K Employee Count 218 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -73.56% in the
last 52 weeks. The beta is 1.9, so Humacyte's
price volatility has been higher than the market average.
Beta 1.9 52-Week Price Change -73.56% 50-Day Moving Average 2.41 200-Day Moving Average 3.26 Relative Strength Index (RSI) 53.95 Average Volume (20 Days) 4,490,985
Income Statement
Revenue n/a Gross Profit n/a Operating Income -114.4M Net Income -148.7M EBITDA -132.23M EBIT -139.42M Earnings Per Share (EPS) -1.26
Full Income Statement Balance Sheet The company has 44.94M in cash and 16.54M in
debt, giving a net cash position of 28.4M.
Cash & Cash Equivalents 44.94M Total Debt 16.54M Net Cash 28.4M Retained Earnings -686.01M Total Assets 162.55M Working Capital 53.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -98.12M
and capital expenditures -1.57M, giving a free cash flow of -99.69M.
Operating Cash Flow -98.12M Capital Expenditures -1.57M Free Cash Flow -99.69M FCF Per Share -0.84
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
